Tyr and Abilify drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Tyr (tyrosine) and Abilify (aripiprazole). Common drug interactions include amnesia among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Tyr and Abilify. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Tyr?
Tyr has active ingredients of tyrosine. eHealthMe is studying from 840 Tyr users. Check the latest studies of Tyr.
What is Abilify?
Abilify has active ingredients of aripiprazole. It is often used in depression. eHealthMe is studying from 101,454 Abilify users. Check the latest studies of Abilify.
12 people who take Tyr and Abilify together, and have interactions are studied.

What are the common drug interactions of Tyr and Abilify, by gender? *:
female:
- Amnesia (deficit in memory caused by brain damage, disease, or psychological trauma)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Asthenia (weakness)
- Brain injury
- Cerebral disorder (brain disease)
- Chest discomfort
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Confusional state
- Drug ineffective
male:
- Anxiety
- Drug ineffective
- Depressed mood
- Disturbance in attention
- Drooling (drop saliva uncontrollably from the mouth)
- Drug hypersensitivity
- Fatigue (feeling of tiredness)
- Fibromyalgia (a long-term condition which causes pain all over the body)
- Hypomania (a mild form of mania, marked by elation and hyperactivity)
- Insomnia (sleeplessness)
What are the common drug interactions of Tyr and Abilify, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
- Blood cholesterol increased
- Migraine (headache)
30-39:
n/a
40-49:
- Chest discomfort
- Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
- Confusional state
- Drug ineffective
- Fatigue (feeling of tiredness)
- Fear
- Flat affect (absence of emotional response to a situation)
- Intentional self-injury
- Lung disorder (lung disease)
- Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
50-59:
n/a
60+:
- Blood pressure decreased
- Drug ineffective
- Therapeutic response unexpected
- Weight decreased
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 41.67%
- Indigestion: 2 people, 16.67%
- Merycism (a rare disease in which food is chewed, swallowed, and then returned to the mouth and chewed again): 1 person, 8.33%
- Affective Disorder (mental disorder): 1 person, 8.33%
- Bipolar Disorder (mood disorder): 1 person, 8.33%
- Blood Pressure Abnormal: 1 person, 8.33%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 1 person, 8.33%
- Drowsiness: 1 person, 8.33%
- Erection Problems: 1 person, 8.33%
- High Blood Pressure: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Tyr and Abilify?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Tyr and Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Tyr:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Abilify:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Tyr and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abilify and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
- Cetin, M., Celik, M., Cakici, M., Polat, M., & Suner, A, "Aripiprazole-Induced Hoarseness", Turk Psikiyatri Dergisi, 2018 Jan .
- Cetin M, Celik M, Cakici M, Polat M, Suner A, "Aripiprazole induced non-cardiogenic pulmonary edema: a case report", Turk Psikiyatri Dergisi, 2014 Dec .
How the study uses the data?
The study uses data from the FDA. It is based on tyrosine and aripiprazole (the active ingredients of Tyr and Abilify, respectively), and Tyr and Abilify (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Daptomycin and Hypokalemic Syndrome for Women aged 60+ - 19 seconds ago
- Daptomycin and Hypokalaemic Syndrome for Women aged 60+ - 19 seconds ago
- Daptomycin and Hypopotassemia for Women aged 60+ - 19 seconds ago
- Daptomycin and Hypokalaemia for Women aged 60+ - 19 seconds ago
- Daptomycin and Potassium - Low for Women aged 60+ - 20 seconds ago
- Daptomycin and Low Blood Potassium for Women aged 60+ - 20 seconds ago
- Daptomycin and Hypokalemia for Women aged 60+ - 20 seconds ago
- Seizures and drugs of ingredients of aspirin; meprobamate - 21 seconds ago
- Haloperidol and Speech Disorder for Men aged 20-29 - 27 seconds ago
- Alcohol and Fever for Men aged 20-29 - 27 seconds ago